MAM
Commonwealth makes senior level appointments at Mumbai
MUMBAI: Commonwealth, the agency formed to service the General Motors creative account globally, has made three senior level appointments at its Mumbai hub.
Loveleen Raina has been roped in as regional business leader. She has prior experience on the GM business and has also been involved in agency operations in Delhi and Mumbai. While at Ogilvy, she has also led the regional hub for Motorola.
Steve Hugh has been appointed as the regional creative director. His earlier stint was at Ogilvy Dubai and he has also worked in Singapore, Malaysia, Vietnam, Hong Kong, New Zealand and the UK. He has experience in automobile having worked in brands such as Volvo, Volkswagen, Toyota and Honda.
Hugh has worked with Colenso BBDO in Auckland, O&M in Singapore for four years and then joined Saatchi & Saatchi Kuala Lumpur as creative director, where he worked on the regional Guinness re-positioning and wrote the “Greatness” tagline that was run globally.
The strategic planning function will be led by Sandip Mahapatra as the regional planning director. This is his second stint with McCann. A few years ago, Mahapatra headed the planning function for McCann North India before leaving for Indonesia. He has worked across the Asian region.
McCann Worldgroup India chairman and CEO and Commonwealth Global board member Prasoon Joshi said, “Commonwealth is a drive for excellence and efficiency and am pleased to have such an experienced and talented leadership leading the Mumbai hub.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
